These findings suggest that CD19 CAR-T therapy may exert therapeutic effects on psoriasis by targeting B cells and modulating the immune microenvironment, offering a new research direction and potential therapeutic strategy for psoriasis treatment and highlighting the need for further exploration of the application and immunological mechanisms of CAR-T cell therapy in psoriasis. The gene discussed is CD19; the disease is psoriasis.